0001415889-24-005156.txt : 20240223
0001415889-24-005156.hdr.sgml : 20240223
20240223203343
ACCESSION NUMBER: 0001415889-24-005156
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240221
FILED AS OF DATE: 20240223
DATE AS OF CHANGE: 20240223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wettig Thane
CENTRAL INDEX KEY: 0001815638
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36740
FILM NUMBER: 24673318
MAIL ADDRESS:
STREET 1: C/O FIBROGEN, INC.
STREET 2: 409 ILLINOIS STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FIBROGEN INC
CENTRAL INDEX KEY: 0000921299
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 409 ILLINOIS STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-978-1200
MAIL ADDRESS:
STREET 1: 409 ILLINOIS STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
4
1
form4-02242024_010232.xml
X0508
4
2024-02-21
0000921299
FIBROGEN INC
FGEN
0001815638
Wettig Thane
C/O FIBROGEN, INC.
409 ILLINOIS STREET
SAN FRANCISCO
CA
94158
false
true
false
false
CEO
0
Common Stock
2024-02-21
4
A
0
166000
0
A
423932
D
Common Stock
1000
I
By spouse
Stock Option (Right to Buy)
1.715
2024-02-21
4
A
0
834000
0
A
2034-02-20
Common Stock
834000
834000
D
Represents the grant of restricted stock units (RSUs). Twenty-five percent of the RSUs will vest on March 6, 2025, and the remainder of the RSUs will vest in equal amounts quarterly thereafter for the following three years.
Twenty-five percent of the shares subject to the option will vest on March 1, 2025, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years.
/s/ Michael Hom, Attorney-in-Fact
2024-02-23